Arkolith/Insider Trading/ZVRA/Form 4

Sangiovanni Timothy J.

SVP, Finance & Corp ControllerZEVRA THERAPEUTICS, INC. (ZVRA) · full profile →Form 4 · filed Feb 3, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2025Option exercise(M)12K——19K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 31, 2025Option exercise(M)12K—$023K
Jan 30, 2025Grant(A)38K—$038K
Jan 30, 2025Grant(A)19K—$019K

Transaction Codes

M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-002629) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML